Rheumatology Network's Top 5: February 26, 2021

Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending February 26, 2021.

Related Videos
Related Content

ACR/AAHKS Introduces Guidelines for Optimal Timing of Knee and Hip Arthroplasty

March 28th 2023

Overdrive Podcast: What's Limiting Medical Marijuana Therapy in Rheumatology?

May 19th 2022

Match Day's Hidden Crisis: Pediatric Rheumatology Struggling to Meet Pace

March 17th 2023

Overdrive Podcast: ArthritisPower Redesign and Research

April 11th 2022

Tumor Necrosis Factor Inhibitors Safely, Effectively Treat Patients With Juvenile Idiopathic Arthritis

March 1st 2023

Sindhu Ramchandren, MD: Nipocalimab may be a Promising New Treatment Option for Myasthenia Gravis

February 28th 2023

ACR/AAHKS Introduces Guidelines for Optimal Timing of Knee and Hip Arthroplasty

March 28th 2023

Overdrive Podcast: What's Limiting Medical Marijuana Therapy in Rheumatology?

May 19th 2022

Match Day's Hidden Crisis: Pediatric Rheumatology Struggling to Meet Pace

March 17th 2023

Overdrive Podcast: ArthritisPower Redesign and Research

April 11th 2022

Tumor Necrosis Factor Inhibitors Safely, Effectively Treat Patients With Juvenile Idiopathic Arthritis

March 1st 2023

Sindhu Ramchandren, MD: Nipocalimab may be a Promising New Treatment Option for Myasthenia Gravis

February 28th 2023

ACR/AAHKS Introduces Guidelines for Optimal Timing of Knee and Hip Arthroplasty

March 28th 2023

Overdrive Podcast: What's Limiting Medical Marijuana Therapy in Rheumatology?

May 19th 2022

Match Day's Hidden Crisis: Pediatric Rheumatology Struggling to Meet Pace

March 17th 2023

Overdrive Podcast: ArthritisPower Redesign and Research

April 11th 2022

Tumor Necrosis Factor Inhibitors Safely, Effectively Treat Patients With Juvenile Idiopathic Arthritis

March 1st 2023

Sindhu Ramchandren, MD: Nipocalimab may be a Promising New Treatment Option for Myasthenia Gravis

February 28th 2023
© 2023 MJH Life Sciences

All rights reserved.